Skip to content

Author

Changjiang Xu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Research progress on de-escalation strategies of dual antiplatelet therapy after acute coronary syndrome

Individualized DAPT de-escalation, guided by dynamic risk assessment using PRECISE‑DAPT and ARC-HBR criteria, optimizes net clinical benefit and should focus on precision antithrombotic strategies in Chinese populations and high-risk subgroups.

Xinyu Liu, Jingjing Liu, Changjiang Xu · 0 citations